Fenofibrate as an anti-cancer treatment: an in vitro study on glioblastoma cells at various oxygen levels and on normal astrocytes
Abstract Fenofibrate, an active pharmaceutical ingredient (API) of the fibrate class approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypercholesterolemia and hyperlipidemia, has emerged as a promising candidate for repurposing in cancer. Indeed, beyond its lipid-lowering...
Salvato in:
| Autori principali: | , , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BMC
2026-05-01
|
| Serie: | Cancer Cell International |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1186/s12935-026-04309-z |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|